Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Can China bring its own pipeline to the market?

Nature Biotechnology volume 22, pages 1497–1499 (2004)Cite this article

An Erratum to this article was published on 01 January 2005

This article has been updated

China is a growing biotech player whose main competitive edge lies in low development costs. But will inexperienced money men and a disinterested pharmaceutical industry hold it back? Sabine Louët investigates.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 01 January 2005

    Nat. Biotechnol. 22, 1497–1499 (2004) On page 1497, col. 2, paragraph 2, the names of a Shanghai consultancy and its CEO were misspelled. The name of the company is General Biologic and the CEO's name is Matt Chervenak.

References

  1. General Biologic. “China Pipeline 2004” (General Biologic, Shanghai, China, 2004) (http://www.generalbiologic.com/).

  2. Anscomb, A. Pharmaceutical outsourcing opportunities post launch. in Kalorama Information Market Intelligence (ed. Heffner, S.) (Kalorama Information, New York, 2004).

    Google Scholar 

  3. Basu, P. Nat. Biotechnol., 22, 263–265, 2004.

    Article  CAS  Google Scholar 

  4. Pearson, S., Jia, H. & Kandachi, K. Nat. Biotechnol. 22, 3–4, 2004.

    Article  CAS  Google Scholar 

  5. Jia, H. Nat. Biotechnol. 22, 368, 2004.

    Article  CAS  Google Scholar 

  6. Liu, J.L. BioEntrepreneur 6 November 2003 (doi: 10.1038/bioent778).

    Google Scholar 

  7. Liu, J.L. Bioentrepreneur 23 October 2003 (doi:10.1038/bioent776).

    Google Scholar 

  8. McNeil, D.G. New York Times, May 14 (2004).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dublin

    Sabine Louët

Authors
  1. Sabine Louët
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Louët, S. Can China bring its own pipeline to the market?. Nat Biotechnol 22, 1497–1499 (2004). https://doi.org/10.1038/nbt1204-1497

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1204-1497

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing